Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $23.2100 (-1.19%) ($22.7500 - $24.3200) on Fri. May. 24, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.61% (three month average) | RSI | 16 | Latest Price | $23.2100(-1.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.7% a day on average for past five trading days. | Weekly Trend | ATRA declines -13.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(49%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.305% in a week (0% probabilities). VXX(-34%) TLT(-13%) VIXM(-10%) UNG(-6%) IFRA(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.305% (StdDev 4.61%) | Hourly BBV | 0 () | Intraday Trend | -1.9% | | | |
|
1 - 5 Day Possible Target | $-6.12(-126.37%) | Resistance Level | $28.05 | 5 Day Moving Average | $23.54(-1.4%) | 10 Day Moving Average | $23.96(-3.13%) | 20 Day Moving Average | $28.05(-17.25%) | To recent high | -44.4% | To recent low | 0.2% | Market Cap | $1.725b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |